Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi) ...

UNIONDALE, NY / ACCESS Newswire / January 30, 2025 / Marquis Who's Who celebrates Antony Jackson Arumairaj, MD, for excellence in medicine. Dr. Arumairaj was recently featured on a 22-story screen in ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of ...

Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

potential regulatory developments in Japan for their COVID-19 treatment Kostaive, along with existing orders, signify a strong revenue stream. Collectively, these elements underscore Arcturus ...

With the first strain of the coronavirus identified over five years ago today, the virus is still ever present. Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of ...

Reports of rising cases of a flu-like illness in China, where COVID-19 was first detected five years ago, sparked international concerns about the potential for another worldwide pandemic.